Skip to main content
. 2017 Sep 22;61(10):e01057-17. doi: 10.1128/AAC.01057-17

TABLE 2.

CLSI-ECVs for S. schenckii sensu stricto and S. brasiliensis based on MICs from 3 to 9 laboratories determined by the CLSI broth microdilution method

Species Antifungal agent No. of isolates tested MIC (μg/ml)
ECVb
Range Modea ≥95% ≥97.5%
S. schenckii Amphotericin B 263 0.03 to 32 1 4 4
Itraconazole 194 0.06 to ≥32 0.5 2 2
Ketoconazole NDc
Posaconazole 301 0.06 to 16 1 2 4
Voriconazole 252 0.5 to >32 16 64 64
Terbinafine ND
S. brasiliensis Amphotericin B 486 0.03 to 8 1 4 4
Itraconazole 306 0.01 to 32 1 2 2
Ketoconazole 338 0.01 to 2 0.5 2 2
Posaconazole 200 0.01 to 4 1 2 2
Voriconazole 200 0.5 to 32 8 32 32
Terbinafine 368 ≤0.01 to 1 0.06 0.12 0.25
a

Mode, most frequent MIC.

b

Calculated CLSI ECVs comprising ≥95% and ≥97.5% of the statistically modeled population; the values are based on MICs determined by the CLSI M38-A2 broth dilution method (21).

c

ND, not determined, due to an insufficient number of isolates or laboratories for ECV calculation.